For all GH secretagogues, the long-term concern is chronically elevated IGF-1 levels
Clinical symptoms include impaired consciousness, seizures, autism spectrum disorder and depression, as well as extrapyramidal and pyramidal fasciculus symptoms
What is missing There is no published human pharmacokinetic study of subcutaneous AOD-9604, no published human topical or intranasal exposure data, no Phase 3 efficacy trial, no long-term safety data beyond 24 weeks, and no published human cartilage or joint outcome data
For partial ligament injuries managed conservatively, rehabilitation focuses on restoring stability, strength, balance, and confidence in the knee
Cytoskeletal & CellMigration Pathways (TB500 Domain) Pollard T.D